Could a Lower-Dose RSV vaccine protect babies just as well?
NCT ID NCT06705140
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a nasal spray RSV vaccine in nearly 1,000 healthy infants and toddlers aged 6 to 22 months. The goal was to see if a lower dose works as well as the standard dose and to check safety across different doses. The trial was ended early, so final results are not available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RSV IMMUNISATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 2140002
Santo Domingo, 10201, Dominican Republic
-
Investigational Site Number : 3400001
Tegucigalpa, 11101, Honduras
-
Investigational Site Number : 3400002
San Pedro Sula, Honduras
-
Investigational Site Number : 3400003
Tegucigalpa, 11101, Honduras
More trials for these conditions
Other studies related to the condition(s) this trial covers.